Literature DB >> 16265610

Cellular immune responses against hepatitis C virus.

Margaret James Koziel1.   

Abstract

Cellular immune responses are typically important in recovery from acute infections, and studies of acute hepatitis C confirm that broadly directed CD4+ and CD8+ T cell responses are associated with spontaneous clearance of infection. However, a major unanswered question is what role the cellular immune response plays in progression of liver disease during chronic infection. Classic models of hepatitis C suggest that cellular immune responses promote liver injury, either by causing direct cytolysis of infected cells or by promoting inflammation. However, clinical evidence suggests that persons with cellular immune dysfunction, such as that due to with human immunodeficiency virus (HIV) infection, have more-rapid disease progression. Recent data suggest that cellular immune responses do serve to limit the progression of liver disease, even if they are ineffective at clearance of virus. There is limited information on the effect of HIV coinfection on the cellular immune response to hepatitis C virus, but further study of this issue might shed light on the pathogenesis of liver disease in both immunocompromised and nonimmunocompromised hosts.

Entities:  

Mesh:

Year:  2005        PMID: 16265610     DOI: 10.1086/429492

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  19 in total

1.  Gender susceptibility to chronic hepatitis C virus infection associated with interleukin 10 promoter polymorphism.

Authors:  Natalia Paladino; Hugo Fainboim; Graciela Theiler; Teresa Schroder; Alberto Eduardo Muñoz; Ana Claudia Flores; Omar Galdame; Leonardo Fainboim
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  Modulation of IL-2 expression after uptake of hepatitis C virus non-enveloped capsid-like particles: the role of p38 kinase.

Authors:  Elisavet Serti; Polyxeni P Doumba; George Thyphronitis; Panagiota Tsitoura; Konstantina Katsarou; Pelagia Foka; Manousos M Konstandoulakis; John Koskinas; Penelope Mavromara; Urania Georgopoulou
Journal:  Cell Mol Life Sci       Date:  2010-07-31       Impact factor: 9.261

3.  Elicitation of strong immune responses by a DNA vaccine expressing a secreted form of hepatitis C virus envelope protein E2 in murine and porcine animal models.

Authors:  Yi-Ping Li; Hye-Na Kang; Lorne-A Babiuk; Qiang Liu
Journal:  World J Gastroenterol       Date:  2006-11-28       Impact factor: 5.742

4.  Immunologic characterization of posthepatitis cirrhosis caused by HBV and HCV infection.

Authors:  Wan-Yu Li; Yan-Fang Jiang; Qing-Long Jin; Hong Zhang; Xiang-Wei Feng; Jun-Qi Niu
Journal:  J Biomed Biotechnol       Date:  2010-06-15

5.  Keratin 18 phosphorylation as a progression marker of chronic hepatitis B.

Authors:  Ying Shi; Shihui Sun; Yali Liu; Junfeng Li; Tong Zhang; Hao Wu; Xinyue Chen; Dexi Chen; Yusen Zhou
Journal:  Virol J       Date:  2010-03-24       Impact factor: 4.099

6.  Toll-like receptor 3-activated macrophages confer anti-HCV activity to hepatocytes through exosomes.

Authors:  Yu Zhou; Xu Wang; Li Sun; Li Zhou; Tong-Cui Ma; Li Song; Jian-Guo Wu; Jie-Liang Li; Wen-Zhe Ho
Journal:  FASEB J       Date:  2016-09-07       Impact factor: 5.191

Review 7.  Underlying pathophysiology of HCV infection in HIV-positive drug users.

Authors:  Anuradha Balasubramanian; Jerome E Groopman; Ramesh K Ganju
Journal:  J Addict Dis       Date:  2008

8.  Resolution of chronic hepatitis C following parasitosis.

Authors:  Valerie Byrnes; Sanjiv Chopra; Margaret J Koziel
Journal:  World J Gastroenterol       Date:  2007-08-21       Impact factor: 5.742

9.  Characterization of antigenic variants of hepatitis C virus in immune evasion.

Authors:  Jane H Wang; Matthew J Pianko; Xiaogang Ke; Alex Herskovic; Ronald Hershow; Scott J Cotler; Weijin Chen; Zheng W Chen; Lijun Rong
Journal:  Virol J       Date:  2011-07-29       Impact factor: 4.099

10.  Ethnic and geographical differences in HLA associations with the outcome of hepatitis C virus infection.

Authors:  Jane H Wang; Xin Zheng; Xiaogang Ke; M Tevfik Dorak; Jingjing Shen; Basmattee Boodram; Maurice O'Gorman; Kenneth Beaman; Scott J Cotler; Ronald Hershow; Lijun Rong
Journal:  Virol J       Date:  2009-05-01       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.